Healthcare AI Solutions

What Are Healthcare AI Solutions?

Health systems use healthcare AI solutions to take routine work off clinicians and staff, from flagging urgent findings on scans to drafting visit notes. Whether a product delivers depends on how much time staff spend checking its output.

The products fall into a handful of groups. Imaging and diagnostic AI flags findings on scans and slides, and it makes up most of the FDA's list of AI-enabled medical devices. Ambient documentation tools listen to a visit and draft the clinical note. Administrative AI handles medical coding and prior authorization. Patient-facing tools answer questions or draft replies to portal messages. Risk prediction models, covered under predictive analytics in healthcare, sit alongside these.

The regulatory load differs sharply between groups. An algorithm that detects a stroke on a CT scan is a regulated medical device. A tool that drafts a note for a clinician to review and sign usually is not in the US, though it still handles protected health information and falls under HIPAA, or under the GDPR in the EU.

Why Are Health Systems Adopting AI Solutions?

• Staff time is the binding constraint. Clinician shortages and burnout limit how many patients a health system can see. Tools that take routine work off clinicians' plates add capacity without new hires.

• Documentation and administrative load keep growing. Clinical notes and payer paperwork consume a large share of the working day. Generative AI targets this work directly, since much of it turns conversations and chart data into structured text.

How Do Health Systems Deploy AI Solutions?

• A governance group reviews each use case. Most large health systems route AI proposals through a committee of clinical, IT, legal, and compliance leaders. The September 2025 guidance from the Joint Commission and the Coalition for Health AI recommends this kind of formal governance, with oversight scaled to each tool's risk.

• Vendors are evaluated on evidence and contracts. Buyers ask whether the model was validated on a population like theirs, and whether the vendor will sign a business associate agreement.

• A pilot measures the promised benefit. A small group of clinicians uses the tool while the team tracks time saved and output quality against a baseline.

• The tool is integrated into the EHR. Placing the AI inside the electronic health record (EHR) workflow keeps clinicians in one system. Major EHR vendors now embed or partner with AI products so clinicians don't have to switch systems.

• Outputs stay under human review. Clinicians review and sign AI-drafted notes and messages, and radiologists confirm flagged findings. This review step keeps clinicians accountable for the final decision.

• Performance and incidents are monitored. Teams track accuracy and user overrides after launch, and the Joint Commission and CHAI guidance encourages voluntary reporting of AI-related safety events.

Which Healthcare AI Products and Frameworks Do Health Systems Use?

• Imaging and diagnostic AI. Aidoc, Viz.ai, and Lunit analyze medical images to flag urgent findings such as strokes or pulmonary embolisms, or to support cancer screening.

• Ambient clinical documentation. Microsoft Dragon Copilot, Abridge and Nabla record the clinician-patient conversation and generate a draft note in the EHR.

• Governance frameworks. The NIST AI Risk Management Framework and the international ISO/IEC 42001 standard give health systems a structure for assessing and monitoring AI tools across their lifecycle, and the Coalition for Health AI adds healthcare-specific responsible AI guidance.

What Are the Key Characteristics of Healthcare AI Solutions?

• Products change after purchase. Vendors retrain models and swap the underlying language model on their own schedule, so a tool can behave differently a few months after go-live. Contracts that require notice of model changes give the governance group a chance to re-test.

• Performance varies by site. A model tested on one population can perform differently on another, a problem covered in depth under predictive analytics in healthcare. For generative tools the same problem shows up across specialties, so a pilot in primary care says little about how a scribe handles oncology or emergency visits.

• Generative output can be wrong in fluent language. Ambient scribes and message drafters occasionally add details that were never said or misattribute statements. These errors read convincingly, so review stays part of the workflow.

• Disclosure duties apply in some states. California's AB 3030, effective January 1, 2025, requires providers to tell patients when generative AI wrote a clinical message that no licensed clinician reviewed.

What Are the Benefits of Healthcare AI Solutions?

• Less time on documentation. The Permanente Medical Group reported in NEJM Catalyst that ambient AI scribes saved its physicians an estimated 15,791 hours of documentation across about 2.5 million encounters between October 2023 and December 2024.

• Faster attention to urgent findings. Imaging AI moves suspected strokes and bleeds to the top of the reading queue, which can shorten time to treatment.

• Higher administrative throughput. Coding assistance and prior authorization automation let the same staff process more claims and requests.

• More attention on the patient during visits. Most physicians in the Permanente rollout reported better patient interactions during visits.

What Are the Challenges of Healthcare AI Solutions?

• Review time eats into the savings. AI-drafted notes need checking before they enter the record. Lighter review frees up time but increases the risk that an error reaches the record, so each organization must set its own balance.

• Evidence of benefit is uneven. Many products show results from vendor pilots or single health systems. Running a local pilot provides stronger evidence, but it can take months before a decision.

• Liability is unsettled. When an AI-assisted decision harms a patient, courts are still working out responsibility between the provider and the vendor. Contracts can assign it, though vendors resist taking on clinical liability.

• Rules differ by jurisdiction. In the US, tools that meet the device definition fall under FDA regulation, and patient-facing generative tools may also fall under state disclosure laws. The EU AI Act's high-risk obligations apply to AI-enabled medical devices on August 2, 2028, with details covered under medical device software development. Selling one product in several markets means designing to the strictest set of requirements.

What Is the Difference Between Embedded EHR AI and Third-Party Healthcare AI?